These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 266179)
1. Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism. Meraldi JP; Hruby VJ; Brewster AI Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1373-7. PubMed ID: 266179 [TBL] [Abstract][Full Text] [Related]
2. Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution. Mosberg HI; Hruby VJ; Meraldi JP Biochemistry; 1981 May; 20(10):2822-8. PubMed ID: 7248250 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the design of antagonists. Hruby VJ; Mosberg HI; Hadley ME; Chan WY; Powell AM Int J Pept Protein Res; 1980 Nov; 16(5):372-81. PubMed ID: 7216613 [TBL] [Abstract][Full Text] [Related]
4. [1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor. Hruby VJ; Deb KK; Yamamoto DM; Hadley ME; Chan WY J Med Chem; 1979 Jan; 22(1):7-12. PubMed ID: 423185 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological, conformational and dynamic properties of cycloleucine-2 analogues of oxytocin and [1-penicillamine]oxytocin. Hruby VJ; Rockway TW; Viswanatha V; Chan WY Int J Pept Protein Res; 1983 Jan; 21(1):24-34. PubMed ID: 6826279 [TBL] [Abstract][Full Text] [Related]
6. Conformational comparisons of oxytocin agonists, partial agonists, and antagonists using laser Raman and circular dichroism spectroscopy. Examination of 1-penicillamine and diastereoisomeric analogues. Hruby VJ; Mosberg HI; Fox JW; Tu AT J Biol Chem; 1982 May; 257(9):4916-24. PubMed ID: 7068672 [TBL] [Abstract][Full Text] [Related]
7. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling. Bélec L; Blankenship JW; Lubell WD J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022 [TBL] [Abstract][Full Text] [Related]
8. Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and bioassay. Fric I; Hlavacek J; Rockway TW; Chan WY; Hruby VJ J Protein Chem; 1990 Feb; 9(1):9-15. PubMed ID: 2340080 [TBL] [Abstract][Full Text] [Related]
9. The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs. Bélec L; Maletinska L; Slaninová J; Lubell WD J Pept Res; 2001 Sep; 58(3):263-73. PubMed ID: 11576333 [TBL] [Abstract][Full Text] [Related]
10. 300-MHz nuclear magnetic resonance study of oxytocin aqueous solution: conformational implications. Brewster AI; Hruby VJ Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3806-9. PubMed ID: 4521206 [TBL] [Abstract][Full Text] [Related]
11. Conformational studies of peptide hormones using laser Raman and circular dichroism spectroscopy. A comparative study of oxytocin agonists and antagonists. Hruby VJ; Deb KK; Fox J; Bjarnason J; Tu AT J Biol Chem; 1978 Sep; 253(17):6060-7. PubMed ID: 681339 [No Abstract] [Full Text] [Related]
12. Conformational studies on [3-D-alanine]-oxytocin and [4-D-alanine]-oxytocin in dimethyl sulfoxide by 1H nuclear magnetic resonance spectroscopy. Interpretation in terms of a beta turn in the cyclic moiety. Walter R; Wyssbrod HR; Glickson JD J Am Chem Soc; 1977 Oct; 99(22):7326-32. PubMed ID: 915154 [No Abstract] [Full Text] [Related]
13. Introduction of a cis-prolyl mimic in position 7 of the peptide hormone oxytocin does not result in antagonistic activity. Wittelsberger A; Patiny L; Slaninova J; Barberis C; Mutter M J Med Chem; 2005 Oct; 48(21):6553-62. PubMed ID: 16220972 [TBL] [Abstract][Full Text] [Related]
14. Conformational preferences and binding to neurophysins of oxytocin analogs with sarcosine or N-methylalanine in position 7. Grzonka Z; Mishra PK; Bothner-By AA Int J Pept Protein Res; 1985 Apr; 25(4):375-81. PubMed ID: 2410380 [TBL] [Abstract][Full Text] [Related]
16. H N.M.R. study of the conformation of [Glu4] oxytocin and its lanthanide complexes in aqueous solution. Walter R; Smith CW; Sarathy KP; Pillai RP; Krishna NR; Lenkinski RE; Glickson JD; Hruby VJ Int J Pept Protein Res; 1981 Jan; 17(1):56-64. PubMed ID: 7228492 [TBL] [Abstract][Full Text] [Related]
17. Long-range, pH-dependent effects on the carbon-13 nuclear magnetic resonance spectra of oxytocin. Deslauriers R; Walter R; Smith IC Proc Natl Acad Sci U S A; 1974 Feb; 71(2):265-8. PubMed ID: 4521798 [TBL] [Abstract][Full Text] [Related]
18. Design of oxytocin antagonists with prolonged action: potential tocolytic agents for the treatment of preterm labor. Chan WY; Hruby VJ; Rockway TW; Hlavacek J J Pharmacol Exp Ther; 1986 Oct; 239(1):84-7. PubMed ID: 3761199 [TBL] [Abstract][Full Text] [Related]
19. 1H n.m.r. investigation of conformational features of cyclic enkephalinamide analogs. Mosberg HI; Schiller PW Int J Pept Protein Res; 1984 May; 23(5):462-6. PubMed ID: 6735586 [TBL] [Abstract][Full Text] [Related]
20. Oxytocin and neurohypophyseal peptides: spectral assignment and conformational analysis by 220 MHz nuclear magnetic resonance. Johnson LF; Schwartz IL; Walter R Proc Natl Acad Sci U S A; 1969 Dec; 64(4):1269-75. PubMed ID: 5271751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]